Crossmark

Drug‐like sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity

Crossref DOI link: https://doi.org/10.15252/emmm.202013086

Published Online: 2021-07-07

Published Print: 2021-08-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Jayashankar, Vaishali

Selwan, Elizabeth

Hancock, Sarah E

Verlande, Amandine

Goodson, Maggie O

Eckenstein, Kazumi H

Milinkeviciute, Giedre

Hoover, Brianna M

Chen, Bin

Fleischman, Angela G

Cramer, Karina S

Hanessian, Stephen

Masri, Selma

Turner, Nigel

Edinger, Aimee L https://orcid.org/0000-0003-4277-4584
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (UL1 TR001414)

National Health and Medical Research Council (1126135)

National Cancer Institute (T32CA009054)

National Cancer Institute (R01 CA254360)
License Information

Version of Record valid from 2021-07-07
More Information

Publication History

Received: 2020-07-09

Accepted: 2021-06-09

Published: 2021-07-07